High Outlier
Strength
.5 mg/1
Manufacturer
E.R. Squibb & Sons, L.L.C.NDC
00003161112
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
11/19/2025
Active Ingredients
ENTECAVIRApproval Type
New Drug (NDA)
FDA Application
NDA021797On Market Since
3/29/2005
Pharmacological Classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Analog
Nucleoside Reverse Transcriptase Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
EPIVIR 10 MG/ML ORAL SOLN
Brand
49702020548•ViiV Healthcare Company
$0.4452
per ML
ZIAGEN 20 MG/ML SOLUTION
Brand
49702022248•ViiV Healthcare Company
$0.5865
per ML
ZOVIRAX 5% OINTMENT
Brand
00187099395•Bausch Health US LLC
$4.7770
per GM
EPIVIR 150 MG TABLET
Brand
49702020318•ViiV Healthcare Company
$6.6144
per EA
INTELENCE 100 MG TABLET
Brand
59676057001•Janssen Products LP
$10.9213
per EA
VALTREX 500 MG CAPLET
Brand
00173093308•GlaxoSmithKline LLC
$12.8168
per EA
VALTREX 500 MG CAPLET
Brand
00173093310•GlaxoSmithKline LLC
$12.8168
per EA
EPIVIR 300 MG TABLET
Brand
49702020413•ViiV Healthcare Company
$13.2940
per EA
COMBIVIR TABLET
Brand
49702020218•ViiV Healthcare Company
$14.3948
per EA
EMTRIVA 200 MG CAPSULE
Brand
61958060101•Gilead Sciences, Inc.
$17.4370
per EA